According to the principles for the appointment of the Nomination Committee in Sedana Medical AB (publ), the Nomination Committee for the Annual General Meeting 2024 shall be composed of members appointed by the three largest shareholders as of September 30, along with the Chairman of the Board of Directors. The composition of the Nomination Committee has now been established, and Sedana Medical announced that the Nomination Committee for the 2024 Annual General Meeting consists of: Claus Bjerre, Chairman of the Board, Karl Tobieson, appointed by Linc AB, Patrik Walldov, appointed by Anders Walldov (including indirect holding via Brohuvudet AB), Monica Åsmyr, appointed by Swedbank Robur Fonder.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.45 SEK | +4.42% | +2.51% | -3.07% |
May. 22 | Sedana Medical AB Approves Election of Jens Viebke and Donna Haire as Board Members | CI |
Apr. 25 | Transcript : Sedana Medical AB, Q1 2024 Earnings Call, Apr 25, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.07% | 201M | |
-58.85% | 83.95M |
- Stock Market
- Equities
- SEDANA Stock
- News Sedana Medical AB
- Sedana Medical AB Establishes Nomination Committee